
Study Finds Way to Overcome KRAS Drug Resistance
Roswell Park researchers report that blocking CDK4/6 or CDK2 kinases restored sensitivity to KRAS- and RAS-targeted therapies in preclinical models.
For readers in Buffalo, this page covers disease outbreaks, risk factor research, clinical trial results and treatment approvals. Reporting centers on the conditions affecting people in the city and the health bodies that respond to them.

Roswell Park researchers report that blocking CDK4/6 or CDK2 kinases restored sensitivity to KRAS- and RAS-targeted therapies in preclinical models.
A health expo at KeyBank Center offered breast, prostate, and lung cancer screenings as part of the Hockey Fights Cancer initiative.
Live Poll
Do you trust intensive lifestyle programs to significantly improve your long-term heart health?
The program provides patients with heart-focused recovery support and lifestyle guidance at a new Buffalo site.

After surviving brain tumor surgery in 2024, a registered nurse transitioned into a career as an author and host.

Live Poll
Do accounts of peaceful end-of-life visions change how you feel about the process of dying?
Dr. Christopher Kerr reported that hospice patients often experienced visions of deceased loved ones.

This section follows public health alerts, disease surveillance, new treatments and the trials that test them, and research into what raises or lowers risk. Coverage reaches across the city and the communities around it wherever a disease story crosses the line. Clinical trial results and the approvals that follow them generate as many stories as outbreaks do. Seasonal illness and the access patterns of local clinics shape which conditions draw the most attention in Buffalo.